Rio de Janeiro State University is a public research university in the state of Rio de Janeiro, Brazil. It is one of the largest and most prestigious universities in the country. The university's law and medical schools are among the best in the nation.

During the past decade, Rio de Janeiro State University conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rio de Janeiro State University" #1 sponsor was "Rio de Janeiro State University" with 8 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Klaus Barretto-Lopes" with 1 trials sponsored, "Mario Fritsch Neves" with 1 trials sponsored and "University of Sao Paulo" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rio de Janeiro State University" #1 collaborator was "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 3 trials as a collaborator, "Iguaçu University" with 1 trials as a collaborator, "Rio de Janeiro State Research Supporting Foundation (FAPERJ)" with 1 trials as a collaborator, "Rio de Janeiro State University" with 1 trials as a collaborator and "Santa Catarina Federal University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Rio de Janeiro State University" are "Obesity" (2 trials), "Alveolar Bone Loss" (1 trials), "Alveolar Rege Preservation" (1 trials), "Athletic Injuries" (1 trials) and "Bone Loss, Alveolar" (1 trials). Many other conditions were trialed in "Rio de Janeiro State University" in a lesser frequency.

Most popular intervention types in "Rio de Janeiro State University" are "Drug" (4 trials), "Other" (4 trials), "Device" (2 trials), "Dietary Supplement" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone acetate (AA)" (1 trials), "Acetaminophen" (1 trials), "Androgen Deprivation Therapy (ADT)" (1 trials), "Apalutamide" (1 trials) and "Chewing gum" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rio de Janeiro State University" are 7 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Rio de Janeiro State University". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Rio de Janeiro State University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rio de Janeiro State University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".

Rio de Janeiro State University has several departments that took part in Clinical trials: "Laboratorio de Pesquisas Clinicas e Experimentais em Biologia Vascular" - 2 trials